Keywords: PharmSintez, Russia, Investment, Plant construction

Russia’s PharmSintez to invest $160 million in construction of new plants

Article | 20 September 2011

Print This

PharmSintez (LFE: RU), one of Russia’s leading pharmaceutical companies, plans to significantly expand its presence in the domestic ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in